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Modulation of functional 
network properties in major 
depressive disorder 
following electroconvulsive therapy 
(ECT): a resting‑state EEG analysis
Aron T. Hill1, Itay Hadas1, Reza Zomorrodi1, Daphne Voineskos1,5, Faranak Farzan2, 
Paul B. Fitzgerald3, Daniel M. Blumberger1,4,5 & Zafiris J. Daskalakis1,4,5*
Electroconvulsive therapy (ECT) is a highly effective neuromodulatory intervention for 
treatment‑resistant major depressive disorder (MDD). Presently, however, understanding of its 
neurophysiological effects remains incomplete. In the present study, we utilised resting‑state 
electroencephalography (RS‑EEG) to explore changes in functional connectivity, network topology, 
and spectral power elicited by an acute open‑label course of ECT in a cohort of 23 patients with 
treatment‑resistant MDD. RS‑EEG was recorded prior to commencement of ECT and again within 
48 h following each patient’s final treatment session. Our results show that ECT was able to enhance 
connectivity within lower (delta and theta) frequency bands across subnetworks largely confined to 
fronto‑central channels, while, conversely, more widespread subnetworks of reduced connectivity 
emerged within faster (alpha and beta) bands following treatment. Graph‑based topological 
analyses revealed changes in measures of functional segregation (clustering coefficient), integration 
(characteristic path length), and small‑world architecture following ECT. Finally, post‑treatment 
enhancement of delta and theta spectral power was observed, which showed a positive association 
with the number of ECT sessions received. Overall, our findings indicate that RS‑EEG can provide a 
sensitive measure of dynamic neural activity following ECT and highlight network‑based analyses as a 
promising avenue for furthering mechanistic understanding of the effects of convulsive therapies.
Electroconvulsive therapy (ECT) can provide effective and fast-acting treatment for patients with major 
depressive disorder (MDD) who fail to respond to conventional  pharmacotherapies1. Response rates typically 
range between 50 and 70%, making it one of the most efficacious treatments in modern  psychiatry2–4. The 
core therapeutic effects of ECT stem from the elicitation of a generalized  seizure5,6. However, considerable 
uncertainty remains with regard to the specific, and likely multifaceted, neurobiological mechanisms which 
drive the clinical effects produced by this  technology4,7. Deeper understanding of the impact of ECT on neural 
circuits in MDD could aid in uncovering physiological markers of treatment response and advancing future 
treatment optimisation.
Electroencephalography (EEG) provides a sensitive and accessible method for non-invasive in vivo recording 
of oscillatory activity across neural populations. Understanding the specific effects that therapeutic technologies, 
such as ECT, can have on neural circuits across different frequencies might provide a window to the physiological 
mechanisms which drive treatment  response8–10. A body of qualitative and quantitative EEG research highlights 
widespread alterations in oscillatory activity following ECT, with generalised slowing being a frequently reported 
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 finding9,11. Increases in slow (delta and theta) power have also been shown to become more manifest with 
increasing numbers of  treatments11–13. Several studies have also shown a positive association between increases in 
spectral power and clinical  response12–14, however this relationship remains uncertain, with other studies failing 
to find a  relationship15,16, or even observing worse clinical outcomes with greater  slowing17 (for review  see9,18). 
In addition to alterations within lower frequency bands, reduced activity within faster (e.g., beta and gamma) 
frequencies has also been reported following  ECT19,20.
More advanced connectivity-based measures have also been integral in elucidating the effects of ECT on 
functional interactions across cortical  networks21. A preliminary report by Krystal et al. indicated increased 
EEG coherence in lower frequency bands (< 8.5 Hz) during a course of ECT; while connectivity within faster 
frequencies became  disrupted22. Deng et al.23 also found reductions in resting-state beta-band connectivity 
shortly (~ 30 min) after a session of convulsive therapy in a small cohort of 10 patients receiving either ECT (n = 7) 
or magnetic seizure therapy (MST; n = 3). Finally, Takamiya et al.15 were able to show a reduction in parieto-
central beta connectivity following ECT in a small cohort of 13 MDD patients; while a concomitant increase 
in theta connectivity between fronto-parietal regions was also observed. Together, these initial studies provide 
some preliminary evidence that ECT can act to modulate EEG-based measures of functional connectivity, while 
also adding to the larger body of neuroimaging literature which has reported both structural and functional 
connectivity changes following  ECT24–28. Nevertheless, larger investigations into the effects of ECT across 
functional networks are clearly needed. The use of EEG-recorded measures are particularly appealing as a means 
of assessing physiological changes associated with convulsive therapies, as EEG provides a cost-effective method 
for obtaining time-sensitive recordings of neural activity, making it practicable for implementation in clinical 
 settings29.
Graph-theoretical approaches, which define the brain in terms of specific regions (nodes) and their 
corresponding connections (edges) provide an additional avenue for exploring functional connections across 
the  brain30,31. Utilisation of these mathematical frameworks has facilitated the identification and characterisation 
of abnormalities within intrinsic structural and functional networks across a number of neuropsychiatric 
disorders, including  MDD32–35. Despite the rapid and recent growth of network neuroscience, exploration 
of functional topological alterations following convulsive therapies remains under investigated. A resting-
state fMRI investigation by Sinha et al. recently showed that ECT could increase functional segregation and 
reduce integration within serval brain regions in a cohort of depressed patients, thus establishing the ability for 
ECT to modulate functional network architecture within the  brain36. To our knowledge, only one EEG-based 
graph-theoretical analysis of ECT-induced changes in network properties exists. In the aforementioned small 
preliminary study combining data from patients taken before and after a single session of either ECT or MST, 
Deng et al.23 reported altered network topology including reduced segregation and integration within the beta 
frequency range indicative of a potential decline in network efficiency. These initial observations thus highlight 
the potential utility of graph-theoretical approaches for characterising functional network topology following 
ECT, but also emphasise the need for further investigations in larger samples.
In summary, both electrophysiological and functional neuroimaging studies indicate modulation of neural 
circuits following ECT, with the most consistent findings on EEG relating to changes in spectral power. However, 
studies investigating changes in more complex EEG dynamics, such as connectivity, and graph-based network 
topology remain limited, whilst also being hampered by very modest sample sizes and the inclusion of multiple 
treatment modalities (e.g., ECT and MST)23. Further research is therefore required to more clearly characterise 
the physiological effects of ECT in MDD. Accordingly, in the present study, we sought to utilise resting-state 
EEG (RS-EEG) recorded in a cohort of treatment resistant MDD patients to evaluate changes in functional 
connectivity, network topology, and spectral power following an acute course of ECT. We further compared 
physiological changes with depression severity scores to identify any potential physiological markers of treatment 
response. Based on previous literature, we anticipated that ECT would result in several discernible changes on 
the quantitative RS-EEG. Specifically, we predicted that following a course of treatment, the record would show 
increased connectivity within slower (delta and theta) frequencies, with a concomitant reduction in connectivity 
across higher (e.g., alpha, beta, gamma) bands. We further predicted an enhancement of spectral power within 
lower frequencies, and reduction in power in higher frequencies. Given the presently very limited EEG-related 
research into graph-based network topology following ECT, we did not make specific predictions regarding 
changes in network architecture.
Methods
Participants. Twenty-three patients with a diagnosis of MDD as per the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) were included in the present study. All patients were classified as having treatment 
resistant depression, defined as no meaningful clinical response to at least two separate antidepressant trials. 
Only patients with complete EEG recordings pre- and post-ECT treatment were included in the present analysis. 
Written informed consent was provided by all patients and the study received ethical approval from the Centre 
for Addiction and Mental Health (CAMH) research ethics committee in accordance with the Declaration of 
Helsinki. The study methods were carried out in accordance with the ethics committee regulations of CAMH. A 
comprehensive list of inclusion/exclusion criteria is provided in Voineskos et al.37.
Electroconvulsive therapy. ECT was administered 2–3 times per week according to an open label 
protocol using a brief-pulse device delivering square-wave pulses (MECTA Corporation, Lake Oswego, 
OR). Subjects commenced treatment with either right unilateral ultra-brief ECT, or bi-temporal ECT based 
on treating physician/patient preference with electrodes placed in accordance with American Psychiatric 
Association  guidelines38. Patients receiving unilateral ECT could be later switched to bi-temporal ECT during 
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the treatment course if they showed an initially poor response to treatment. Anaesthesia was achieved using 
methohexital for sedation and succinylcholine for muscle relaxation. Cessation of the ECT course was based on 
patient response, clinical factors, the patient’s desire to discontinue treatment, or the most responsible physician’s 
clinical  judgement37. A detailed overview of the ECT administration procedure is provided in Voineskos et al.37.
EEG recording and data pre‑processing. Baseline EEG recordings were collected in the week 
immediately prior to commencement of the ECT treatment course. Post-treatment EEG recordings were 
performed within 48  h of the final treatment session. A 64-channel cap (Neuroscan Quik-Cap) containing 
sintered Ag/AgCl electrodes connected to a  SynAmps2 amplifier (Neuroscan, Compumedics, USA) was used 
for all recordings (online reference and ground electrodes located at the vertex, and just posterior to Fz, 
respectively). EEG was recorded for 10 min while subjects remained seated with their eyes closed (sampling 
rate: 10 kHz, low and high-pass filters at 1 kHz and 0.05 Hz, respectively). Impedances were maintained below 
5kΩ throughout the recording. EEG pre-processing is described in detail in the supplementary materials. Briefly, 
data were down-sampled to 1 kHz, bandpass filtered (1–70 Hz; zero-phase Butterworth filter) with a band-stop 
filter (58–62 Hz) applied to remove line noise before being segmented into three-second epochs with artefacts 
removed using a combination of automated  EEGLAB39 processes and independent component analysis (ICA).
Neurophysiological measures. Functional connectivity. Connectivity was calculated across all pairs 
of electrodes for each frequency band using the debiased estimate of the weighted phase-lag index (wPLI) in 
 Fieldtrip40. This method was chosen as it has been shown to provide a conservative and reliable estimate of phase 
synchronization between electrodes and is also able to prevent volume conduction effects from affecting the 
result (i.e., values with zero or π phase-lag)41,42. wPLI is also robust to any noise within the data set, including 
that related to a common  reference41–43. Results were then averaged across each individual frequency band (delta 
through gamma), resulting in a weighted matrix of undirected connectivity strengths for each separate frequency 
band for each subject (see Supplementary Fig. S1 online for a graphical overview of the data processing and 
analysis pipeline).
Network topology. Graph-based analyses were performed using the Brain Connectivity Toolbox (BCT) in 
 MATLAB44. In the present EEG data, the nodes represented individual electrodes, while the edges were the wPLI 
connectivity values between electrode pairs. As is customary, a proportional weight thresholding procedure was 
performed to remove spurious (low weight) edges from the connectivity matrices which potentially obscure 
the topology of stronger  connections44. As thresholding limits are typically arbitrary and can influence network 
topology, we applied multiple thresholds which preserved between 10 and 90% of the strongest weights (5% 
increments). All weights below the threshold (and all self-self connections between nodes [i.e., main diagonal 
of the adjacency matrix]) were set to zero, with weights above the threshold set to one, thus establishing a 
series of binary adjacency  matrices44. Similar approaches are often employed prior to conducting topological 
 analyses45–47. We focused on measures of global functional network segregation and integration. Segregation 
relates to the propensity for neural processes to occur within densely interconnected circuits (i.e., cliques or 
clusters), thus facilitating specialisation within a network; while integration describes the brain’s capacity to 
exchange information across distributed  networks44,48. Segregation and integration can be measured using 
the clustering coefficient, C, and characteristic path length, L,  respectively30,48.We further calculated network 
small world architecture, SW, using the formula SW = [C/Crand]/[L/Lrand]49, where Crand and Lrand represent the 
clustering coefficient and characteristic path length, respectively, derived from generated synthetic random 
networks created using code provided in the BCT  toolbox44 and containing the same number of nodes and edges 
as those in the EEG-derived data. Using this formula, any network displaying SW properties can be classified as 
having a value > 149,50.
Spectral power. EEG power spectra were calculated using  Fieldtrip40 incorporating a multi-taper fast-Fourier 
transform with a Hanning taper (1 to 55 Hz, frequency resolution of 0.5 Hz). Power values were then averaged 
across each frequency band: delta (1–3  Hz), theta (4–7  Hz), alpha (8–12  Hz) beta (13–29  Hz) and gamma 
(30–55 Hz) and were averaged across all trials.
Clinical measures. Demographic and medication information was recorded at baseline during a clinical 
interview (Table 1). The primary measure of clinical response was the 17-item Hamilton Depression Rating Scale 
(HDRS-17) which was completed at baseline and within 48 h following the ECT treatment course. Treatment 
response was defined as ≥ 50% reduction in HDRS-17 score following  treatment37.
Associations between neurophysiological clinical measures. Where significant pre-to-post ECT 
differences were obtained for any neurophysiological measures (i.e., connectivity, network topology, or spectral 
power), further comparisons were made with MDD severity scores (HDRS-17) to assess for any potential brain-
behaviour relationships. In all instances, correlations were performed using change-from-baseline scores (i.e., 
POST–PRE). In the case of results from the connectivity and spectral power analyses, which utilised multi-
channel cluster-based statistical approaches (see below for details), assessments were performed for network 
connections (connectivity) or electrode clusters (spectral power) showing significant pre-to-post differences. 
For graph-theoretical results where more than one network threshold showed significance within a specific 
frequency band, the average across all network weights showing significance was used for the correlations. To 
assess for any predictive associations between neurophysiological variables and responder status we also ran 
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receiver operating characteristic (ROC) analyses between neurophysiological change scores and responder 
status (as a binary variable: 1 = responder, 0 = non-responder). Finally, given previous reports of a potential 
association between EEG spectral power changes and the number of ECT treatments received (e.g.,13,16,17), we 
ran correlations between these two measures to explore a potential relationship in our current dataset.
Statistical analysis. The Network Based Statistic (NBS)  toolbox51 was used to conduct statistical comparisons 
between the pre- and post-ECT connectivity data. This validated approach utilises non-parametric statistics 
which have been demonstrated to yield good statistical power while controlling for multiple  comparisons51. 
The primary threshold (test-statistic) for electrode pairs was set to a conservative value of t = 3.8 (equivalent 
to p = 0.001) to ensure that only highly robust and reliable connectivity differences would be compared at the 
cluster  level51–53. A value of p < 0.05 (two-tailed) was used as the secondary significance threshold for family-wise 
corrected cluster analysis (5000 permutations)51,52. Subsequent visualization of brain networks was performed 
using the BrainNet viewer  toolbox54. For network topology, the graph theory derived measures of C, L, and 
SW were analysed pre-to-post ECT via non-parametric Wilcoxon signed-rank tests run separately across each 
frequency band and binary network weight (10–90%). As brain networks with different sparsity levels may be 
considered independent graphs, multiple comparison corrections were not  performed44,45,55. Non-parametric 
cluster-based permutation statistics implemented in Fieldtrip were used to test for statistical differences 
in EEG power within each frequency band. This approach allows for examination of global effects across all 
electrodes while controlling for multiple  comparisons56. Clusters were defined as > 2 neighbouring electrodes 
with a p-statistic < 0.05. Monte Carlo p-values (p < 0.05, two-tailed) were then subsequently calculated (2000 
iterations). Correlation analyses were conducted using the Graphpad Prism software (version 8) between the 
neurophysiological and clinical (i.e., HDRS-17 scores) data. Pearson correlations were used where data were 
normally distributed; otherwise Spearman rank-order correlations were conducted. Prior to running parametric 
statistics, the data were screened for the presence of extreme outliers (ROUT method, Q = 0.5%)57 which were 
then winsorized to one unit larger/smaller than the next largest data point in the distribution to reduce their 
 impact58,59. ROC curve analyses were performed using SPSS (version 25).
Results
The present sample consisted of 9 male and 14 female patients with a mean age of 47.29 ± 16.75 years. Patients 
received, on average, 13.87 ± 5.32 ECT treatments with an average reduction of MDD severity, as measured by 
the HDRS-17, of 48.92% following the treatment course (responder percentage = 60.87%; see Table 1 for subject 
demographics and Fig. 1A for a plot of depression scores before and after treatment). 21 patients commenced 
ECT treatment with right unilateral ECT, and two started with bi-temporal ECT. Seven patients commencing 
treatment with unilateral ECT switched to bi-temporal ECT during their course of treatment; this occurred if 
patients showed an initially poor response to treatment.
Functional connectivity. ECT was found to modulate connectivity across multiple frequency bands. 
Specifically, a significant subnetwork of enhanced delta connectivity (p = 0.016) consisting of five edges spanning 
six right fronto-central nodes was observed. A bilateral subnetwork of increased theta connectivity (p = 0.010) 
was also found consisting of eight edges across nine nodes largely confined to fronto-central regions. These 
connectivity increases were further accompanied by widespread subnetworks of reduced in alpha connectivity 
(131 edges spanning 56 nodes; p < 0.001), as well as a bilateral subnetwork of reduced beta connectivity (24 edges 
spanning 20 nodes; p = 0.004) spanning frontal, central and posterior channels (Fig. 1B). No significant changes 
in gamma connectivity were observed. Secondary comparisons analysing responders and non-responders to 
treatment separately indicated widespread alpha (203 edges spanning 55 nodes; p < 0.001) and beta (75 edges 
Table 1.  MDD subject demographics and clinical characteristics.
Variable Descriptive statistics
N 23.00
Age (mean ± SD) 47.29 ± 16.75
Gender (M/F) 9/14
Years education (mean ± SD) 14.57 ± 2.90
No. ECT treatments received during trial (mean ± SD) 13.87 ± 5.32
HDRS-17 pre (mean ± SD) 24.61 ± 3.80
HDRS-17 post (mean ± SD) 12.57 ± 6.66
Depression severity (moderate/severe/unknown) 9/8/6
Responders (%) 60.87
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spanning 42 nodes; p = 0.003) subnetworks of reduced connectivity in the responder sub-group following ECT 
(Fig. 2). Conversely, no significant changes were found for non-responders in any frequency band. Finally, we 
also ran additional comparisons between responders and non-responders at baseline to assess for any potential 
differences between the two sub-groups prior to the course of ECT. These analyses revealed no significant 
connectivity differences between the sub-groups prior to treatment (p > 0.05 for all frequency bands; further 
output from the NBS analyses can be found in the Supplementary Figs. S2, S3).
Network topology. Changes in topological network properties were observed across a number of 
frequencies (Fig. 3). Reductions in C were found for the delta (network density [ND]: 25–35%) and gamma (ND: 
85%) bands, with an increase in the theta band (ND: 40–55%, 70–80%). L was increased across both the alpha 
(ND: 55%) and gamma (ND: 25%) bands. Finally, while network topology both pre and post ECT demonstrated 
small world organization across a range of densities (i.e., SW > 1), SW was reduced in the delta (ND: 30–40%) 
and gamma (ND: 30%) bands and increased in the theta (ND: 45–55%, 65–85%) band following treatment.
Spectral power. Following ECT, cluster-based analyses revealed robust and widespread power increases 
within the delta (p < 0.001) and theta (p < 0.001) frequency bands (Fig. 4A). Effect sizes (Cohen’s d) for these 
changes, calculated using the average power across all channels forming the significant clusters, were d = 0.70 for 
the delta band and d = 1.00 for the theta band. No significant changes were observed at any other frequency (a 
list of all electrodes forming the significant clusters is provided in Supplementary Table S1).
Associations between neurophysiological clinical measures. Correlations between HDRS-17 
depression ratings and connectivity change scores did not reach significance for any frequency band (all p > 0.05). 
None of the graph theoretical measures correlated with clinical outcome (all p > 0.05); nor did changes in delta 
or theta power (all p > 0.05). However, a significant association was present between spectral power changes and 
the number of treatments received, with greater increases in both delta (r = 0.630, p = 0.001) and theta (r = 0.668, 
p = 0.001) bands associated with more ECT treatments (Fig. 4B). ROC curve analyses did not find any of the 
neurophysiological measures to be able to significantly predict clinical response (all p > 0.05).
Figure 1.  Patient depression scores pre- and post-ECT, as well as network-based changes in functional 
connectivity. (A) Depression scores (HDRS-17 total score) before and after ECT. (B) EEG connectivity changes 
following the course of ECT. Images display functional subnetworks identified using the network based statistic 
(NBS) as showing differences pre-to-post treatment. Networks with edges represented by warmer colours (i.e., 
delta and theta; top row) indicate a post-treatment increase in connectivity, while cooler colours (i.e., alpha and 
beta; bottom row) indicate a post-treatment reduction in connectivity. Accompanying bar graphs depict the 
average connectivity strength across all edges comprising the significant subnetwork (error bars denote SEM). 
The total number of nodes and edges comprising each significant subnetwork is also presented. Across all 
MDD subjects the ECT treatment course increased theta and delta connectivity in fronto-central regions, while 
causing more widespread reductions in alpha and beta connectivity.
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Discussion
Despite many decades of successful use as a treatment for severe MDD, understanding of the neurobiological 
mechanisms which drive the therapeutic effects of ECT remains incomplete. Analysis of resting-state brain 
activity can provide important insight into alterations in spontaneous (i.e., task independent) neural activity 
across intrinsic functional brain circuits that arise in response to neuromodulatory  interventions43,60. The present 
study aimed to examine the effects of an acute course of ECT on resting-state brain activity through analysis 
of EEG-based measures of functional connectivity, network topology, and spectral power. Overall, our results 
demonstrate changes across each of these metrics following treatment, thus indicating the ability for ECT to 
modulate resting-state neural dynamics in patients with treatment resistant MDD. These results add to the 
growing body of knowledge surrounding the mechanisms underlying convulsive therapies for the treatment of 
severe neuropsychiatric disorders.
Effects of ECT on functional connectivity. ECT was shown to modulate network-based measures of 
RS-EEG connectivity, with significant changes observed across each of the delta, theta, alpha, and beta frequency 
bands. Research investigating the effects of ECT on EEG-derived measures of functional connectivity remains 
very limited. Preliminary work by Krystal et al.22 (and discussed  in18) reported increased coherence within lower 
frequency bands (defined as < 8.5 Hz), as well as a reduction in higher frequencies following ECT. This finding 
appears consistent with our present results which, through the use of network-based analyses comparing pre-
Figure 2.  Functional connectivity changes in ECT responders only. In this sub-group, ECT caused widespread 
reductions in alpha and beta connectivity. Accompanying bar graphs depict the average connectivity strength 
across all edges comprising the significant subnetwork (error bars denote SEM). The total number of nodes and 
edges comprising each significant subnetwork is also presented.
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to-post ECT recordings, elucidated subnetworks of increased theta and delta connectivity which were largely 
confined to fronto-central channels (Fig. 1B). In addition to the theta and delta connectivity changes, we also 
found further, and more widespread, reductions in connectivity following ECT in the alpha and beta bands, 
with subnetworks consisting of many long-range connections spanning anterior and posterior channels, 
especially in responders. A previous preliminary study by Deng et al.61 which reported results from 10 MDD 
subjects undergoing either ECT (n = 7) or MST (n = 3) also showed reduced beta connectivity on the RS-EEG 
recorded approximately 30  min after the seizure therapy session. Recently, Takamiya et  al.15 also reported 
diminished RS-EEG connectivity within the beta band following ECT (measured as source-localised beta 
phase synchronisation), with a concomitant increase in theta connectivity in a small sample (N = 13) of MDD 
patients. Our present findings therefore largely corroborate with these previous reports, whilst also extending 
the observed connectivity changes to the alpha band (i.e., reduction in alpha connectivity following ECT) in a 
larger cohort consisting of 23 patients, all of whom underwent an acute course of ECT treatment alone.
Our additional sub-group analyses examining connectivity changes separately in treatment responders and 
non-responders were further indicative of widespread reductions in alpha and beta connectivity in responders, 
but not non-responders. Although cautious interpretation of these results is warranted, given the modest sample 
sizes of these sub-groups, they nevertheless provide some initial evidence of a link between reduced connectiv-
ity within these frequency bands and response to ECT. More broadly, this finding also adds to past literature 
highlighting a putative role for alpha-band connectivity as a neurophysiological marker of treatment response 
in MDD. For example, a large EEG study by Iseger et al.62 showed reduced alpha connectivity in male respond-
ers to a trial of antidepressant medication (Escitalopram, Sertraline, or Venlafaxine-XR). Pre-treatment alpha, 
beta, and gamma band connectivity has also been shown to moderate antidepressant (sertraline hydrochloride 
or placebo) treatment outcome in a recent large multi-centre study using a novel power envelope connectiv-
ity  approach63; while lower pre-treatment alpha-band connectivity has been observed in responders to  ECT64. 
Although further work is needed to better elucidate the underlying mechanisms responsible for the observed 
connectivity changes in the present study, a recently proposed connectivity resetting hypothesis9 might aid in 
partially explaining these findings. This postulates that the therapeutic efficacy of ECT is grounded in its ability 
to reset aberrant functional connectivity patterns within neural networks. The attenuation of alpha and beta con-
nectivity seen in responders might therefore reflect effective ECT-induced restoration of dysfunctional neural 
circuits in these subjects resulting in considerable clinical improvement (i.e., ≥ 50% increase in HDRS-17 score). 
A previous fMRI study by Abbott et al.24 also supports this idea, showing that ECT could normalise connectivity 
differences between healthy and depressed subjects which were present prior to treatment. Future work aimed 
at first identifying RS-EEG network connectivity differences between MDD subjects and healthy controls and 
then attempting to characterise changes within these potentially dysfunctional networks following ECT could 
therefore help provide further cross-modal support for our present findings. Replication in additional cohorts 
could also further establish the role of reduced alpha connectivity as a putative treatment-emergent biomarker.
Effects of ECT on network topology. Our graph-based topological analyses indicate a tendency for 
ECT to modulate network properties corresponding to both segregation and integration on the RS-EEG across 
several frequency bands. Specifically, segregation, as measured by the clustering coefficient, C, was shown to 
decline following treatment in both the delta and gamma bands, and increase in the theta band. Functional 
integration, which is inversely related to path length, declined within the alpha and gamma bands following 
ECT (i.e., these frequencies showed increased characteristic path length, L, following treatment). When taken 
together, these findings indicate a propensity for ECT to modulate network topology in a frequency-specific 
manner, thus echoing the results of our network-based connectivity analyses which also showed distinct patterns 
of either increased (delta and theta bands), or reduced connectivity (alpha and beta bands) following ECT. The 
reduction in C in the delta and gamma bands can be interpreted as these networks showing a greater level of 
randomness with an overall loss of segregated neural  processing30,44; while conversely, within the theta band, 
the network tended towards a more complex architecture, with greater clustering or cliquishness indicative of 
greater local efficiency. The increase in L (representing the average shortest path length between all pairs of nodes 
within the  network44), within the alpha and gamma bands following ECT further indicates a reduced capacity for 
functional integration (i.e., lower capability for parallel information transfer) within these frequencies following 
treatment. That is, for information to flow within the network, it would, on average, need to traverse a greater 
number of functional  connections65. The pattern of increased L and reduced C we observed in the gamma band 
following ECT has also been reported on RS-EEG by Deng et al.23 within the beta frequency range. Specifically, 
these authors found topological beta-band changes shortly after seizure therapy (either ECT or MST). Similarly, 
a graph-based analysis by Sinha et al. using fMRI also observed an increase in path length following  ECT36. 
These results also tie-in with our findings of reduced small world architecture in the gamma band, and are 
indicative of a reduction in overall connectivity and network efficiency (i.e., both decreased C and increased 
L)66. When taken together, the present findings can be more broadly interpreted as changes affecting multiple 
cortical systems across several oscillatory frequencies, including alterations to measures of both network 
integration and segregation. However, despite these observations, the lack of any significant association between 
topological changes and depression severity scores renders their clinical significance uncertain. As past research 
has identified some relationships between network topology and cognitive  performance67–69, future research 
exploring potential associations with ECT-induced neurocognitive changes might be worthwhile.
Effects of ECT on spectral power. Our observation of widespread power increases within the delta and 
theta bands is consistent with reports from a number of previous qualitative and quantitative  studies9,11,14,18,70 and 
attests to the replicability of this phenomenon. Additionally, the extent of both theta and delta slowing was directly 
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related to the number of treatments received, with greater spectral power changes observed in subjects receiving 
higher numbers of ECT sessions (Fig. 4B). Similar observations of a link between slowing on the EEG record and 
the number of ECT treatments received have been documented by others. For example, Mosovich et al.17 showed 
that subjects receiving larger numbers of treatments had a higher likelihood of displaying abnormal patterns of 
slowing (cerebral dysrhythmia) on the EEG, while  Volavka16 also reported similar observations, however in their 
study the relationship between the number of ECT sessions and EEG slowing was confined to the delta band.
We did not observe any association between EEG spectral power changes and clinical response. One potential 
explanation for this finding is that these changes might simply be a direct consequence of the electrical stimula-
tion, or might represent residual post-ictal changes which are unrelated to the clinical effects of ECT. Indeed, 
several previous studies have also failed to find direct associations between activity patterns on EEG and depres-
sion  ratings15,16,71. However, associations between increased slowing and clinical outcome have been reported by 
 others12,14,70,72. These disparate findings might stem from methodological differences between studies, as well as 
intrinsic variability in response to convulsive therapies across patient cohorts. Additionally, many earlier reports 
used qualitative, rather than quantitative, analyses of the EEG record which are likely to have been less objective 
and lacked the sensitivity of modern quantitative analysis techniques. These heterogeneous findings indicate 
that further work is needed to disambiguate the relationship, if any, between spectral power changes and clinical 
and cognitive responses to convulsive therapies. Future well-powered studies could explore this in more detail, 
including a wider array of clinical and neurocognitive assessments.
Limitations of the study. The present results should be interpreted in light of several limitations. First, 
as both unilateral and bilateral ECT treatments were administered (determined based on clinical grounds), we 
Figure 4.  (A) Spectral power pre- and post-ECT treatment. The vertical grey bar highlights the portion of the 
graph corresponding to the delta and theta frequency ranges, both of which showed a significant increase in 
power following treatment. Topographical maps highlight the electrodes (white circles) forming the significant 
clusters and indicate widespread increases in spectral power (note power is plotted in decibel format to aid 
visualization). (B) Association between the change in delta and theta power and the total number of ECT 
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cannot comment on the specificity of these results to a particular ECT montage. Electric field models indicate 
quite diffuse current flow patterns following ECT, with both unilateral and bilateral montages producing 
widespread intra-cerebral currents (> 90% of the brain), regardless of electrode  placement73,74. Thus, in either 
case, our findings are likely to be driven by extensive patterns of activation across cortical and sub-cortical 
networks. Nevertheless, larger future prospective studies comparing changes in EEG-based measures of 
connectivity following different ECT montages would be beneficial for elucidating exactly how this affects brain 
dynamics following treatment. Second, as we recorded EEG before ECT, and again shortly after (within 48 h) 
completion of the final treatment session for each subject, we cannot comment on any longer-term dynamic 
changes which might transpire over the weeks/months following the acute treatment course. Future studies 
aiming to characterise changes in connectivity and network topology as they progress across time could 
provide valuable insight into the ongoing effects of seizure therapy on the RS-EEG dynamics. Also, although we 
compared the physiological effects of ECT with changes in depression ratings, we did not include comparisons 
with any additional neurocognitive measures. Given that ECT has been shown to disrupt a number of cognitive 
 processes75,76, it would be worthwhile for future studies to further explore any potential associations between 
changes in cognition and RS-EEG activity. Finally, the specificity of findings of widespread reductions in alpha 
and beta connectivity following ECT in responders, but not non-responders, is somewhat limited by the absence 
of a sham condition. Thus, we cannot conclusively state that any of the observed changes are related to ECT 
treatment alone.
Conclusions. In conclusion, the results of this study highlight several key physiological changes on the 
RS-EEG following a course of ECT treatment in MDD. First, we found relatively localised and anteriorly 
predominant subnetworks of increased connectivity within delta and theta frequencies; while broader 
disconnected networks within faster alpha and beta bands were also observed. Graph-based topological analyses 
further revealed changes reflecting modulation of both network segregation and integration, as evidenced by 
modulation of network clustering coefficient (C; delta, theta, and gamma bands) and average path length (L; 
alpha and gamma bands); while small world architecture was also altered (delta, theta, and gamma bands). 
Finally, ECT was found to elicit strong increases in delta and theta spectral power, with these increases showing 
a direct association with the number of treatments received. Together, these results indicate widespread changes 
in spontaneous neural activity following an ECT treatment course in treatment resistant MDD. Future work 
comparing resting, as well as task-related neural activity to a variety of clinical and cognitive outcome measures 
is required to elucidate those changes most closely associated with clinical improvement and adverse effects.
Data availability
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